Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,865 | 28,412 | 25,239 | 21,638 | 16,136 |
| Marketable Securities | 200 | 100 | 9,122 | 10,064 | 14,195 |
| Receivables | N/A | N/A | N/A | 1 | 78 |
| Other current assets | 143 | 200 | 375 | 1,224 | 1,241 |
| TOTAL | $23,208 | $28,712 | $34,736 | $32,927 | $31,650 |
| Non-Current Assets | |||||
| PPE Net | 71 | 57 | 64 | 67 | 80 |
| Investments And Advances | 0 | 0 | 0 | 0 | 1,702 |
| Intangibles | 3,208 | 3,208 | 3,208 | 3,208 | 3,208 |
| Other Non-Current Assets | 176 | 137 | 74 | 79 | 81 |
| TOTAL | $3,455 | $3,402 | $3,346 | $3,354 | $5,071 |
| Total Assets | $26,663 | $32,114 | $38,082 | $36,281 | $36,721 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,250 | 5,278 | 7,028 | 5,834 | 5,084 |
| Accrued Expenses | 178 | 669 | 433 | 263 | 138 |
| TOTAL | $6,584 | $6,192 | $7,737 | $6,373 | $5,498 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 156 | N/A | 156 | 156 | 156 |
| Other Non-Current Liabilities | 2,663 | 2,674 | 2,639 | 2,655 | 2,672 |
| TOTAL | $2,663 | $2,674 | $2,639 | $2,655 | $2,672 |
| Total Liabilities | $9,247 | $8,866 | $10,376 | $9,028 | $8,170 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 69,079 | 61,550 | 61,179 | 58,921 | 58,586 |
| Common Shares | 62 | 62 | 61 | 59 | 57 |
| Retained earnings | -348,169 | -341,764 | -336,450 | -330,602 | -325,448 |
| Other shareholders' equity | -357 | -357 | -357 | -357 | -357 |
| TOTAL | $17,416 | $23,248 | $27,706 | $27,253 | $28,551 |
| Total Liabilities And Equity | $26,663 | $32,114 | $38,082 | $36,281 | $36,721 |